Lancet (London, England) · 2019
The public health control of scabies: priorities for research and action.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Engelman Daniel, Cantey Paul T, Marks Michael, Solomon Anthony W, Chang Aileen Y, Chosidow Olivier, Enbiale Wendemagegn, Engels Dirk, Hay Roderick J, Hendrickx David, Hotez Peter J, Kaldor John M, Kama Mike, Mackenzie Charles D, McCarthy James S, Martin Diana L, Mengistu Birhan, Maurer Toby, Negussu Nebiyu, Romani Lucia, Sokana Oliver, Whitfeld Margot J, Fuller L Claire, Steer Andrew C
Аннотация
Scabies is a parasitic disease of the skin that disproportionately affects disadvantaged populations. The disease causes considerable morbidity and leads to severe bacterial infection and immune-mediated disease. Scientific advances from the past 5 years suggest that scabies is amenable to population-level control, particularly through mass drug administration. In recognition of these issues, WHO added scabies to the list of neglected tropical diseases in 2017. To develop a global control programme, key operational research questions must now be addressed. Standardised approaches to diagnosis and methods for mapping are required to further understand the burden of disease. The safety of treatments for young children, including with ivermectin and moxidectin, should be investigated. Studies are needed to inform optimum implementation of mass treatment, including the threshold for intervention, target, dosing, and frequency. Frameworks for surveillance, monitoring, and evaluation of control strategies are also necessary.